Summary

Isolatie en Voortplanting van circulerende tumorcellen uit een muis Cancer

Published: October 09, 2015
doi:

Summary

Circulating tumor cells (CTCs) have been shown to play an important role in tumor metastasis. Here, a method for the isolation and propagation of CTCs from the whole blood of a syngeneic mouse tumor model of hepatocellular carcinoma (HCC) metastasis is described.

Abstract

Cancer metastasis is the foremost cause of cancer-associated deaths. Recent studies have shown that circulating tumor cells (CTCs) are important in cancer metastasis. Indeed, the number of CTCs correlates with tumor size. Here, a detailed description is provided of a methodology for isolation and propagation of CTCs from a syngeneic mouse model of hepatocellular carcinoma (HCC) which allows for downstream analysis of potentially important molecular mechanisms of solid organ tumor metastasis. This method is efficient and reproducible. It is a non-invasive technique and, therefore, has potential to replace the invasive biopsy of tissues from humans which may be associated with complications. Therefore, the method discussed here allows for the isolation and propagation of CTCs from whole blood samples such that they can be examined and characterized. This has potential for future adaptation for clinical applications such as diagnosis, and personalized targeted therapy.

Introduction

The cancer research community has known of the existence of circulating tumor cells (CTCs) since first being observed by Thomas Ashworth in 18691. Since then, CTCs have been shown to be important in tumor metastasis and disease progression2-5. Today, solid tumors are a major cause of morbidity and mortality worldwide. CTCs are rare cells that originate from primary tumors and travel through the blood stream to different organs of which only a small fraction ultimately develop into metastasis2-5. Notably, there is positive correlation between tumor size and CTC number3,4.

An understanding of CTC biology can contribute to the search for targeted therapy. Furthermore, CTCs may have diagnostic applications. To achieve these potential clinical applications, one needs to overcome some current challenges to studying CTCs. One challenge is related to the fact that CTCs may be present as single cells or as clusters and they may even be able to change their phenotype in response to the blood microenvironment2. Moreover, detection can be very challenging, in part, due to the low count of CTCs (a few to hundreds per milliliter) among one billionhematologic cells per milliliterin the blood6. Nevertheless, in recent years, research into the potential clinical applications of CTCs from solid organ cancers has intensified.

Despite these efforts, the challenges of studying and understanding the role of CTCs persist due to the rarity of CTCs and the inadequacy of the technological tools currently available. Despite these challenges, the tremendous potential for clinical applications continues to be an incentive to pursue research into the role of CTCs in cancer metastasis.

We were recently successful in isolating and propagating in cell culture CTCs from an orthotopic syngeneic mouse model of hepatocellular carcinoma (HCC) metastasis5. The purpose of the current paper is to describe in detail all aspects of the successful methodology. The significance of this methodology lies in the fact that this approach may be modified in order to successfully isolate and propagate in culture human CTCs, thus enhancing the possibility of in vitro studies of CTC biology.

There are multiple potential clinical applications for the use of CTCs. CTCs may be useful for prognosis, response monitoring, screening, dynamic monitoring of tumor molecular alterations, and personalized therapy4. Therefore, a better understanding of the biology of CTCs has high potential for clinical impact.

Protocol

Ethiek Verklaring: Alle dierproeven werden goedgekeurd door de Institutional Animal Care en gebruik Comite (IACUC) van Hunter College van de City University van New York. 1. Pre-experiment Procedures Bij aankomst in het dierverblijf aanvankelijk huis 3 BALB / c muizen een kooi met een gefilterde top en houtsnippers beddengoed. Zorg ervoor dat de muizen hebben gratis toegang tot voedsel, Purina knaagdieren voer en water. Beddengoed en voedsel moet tweemaal per week worden gewijzigd…

Representative Results

De hier beschreven methode heeft aangetoond dat CTCs worden geïsoleerd. Muizen werden op humane wijze gedood bij experimentele eindpunt. Het proces betrokken kooldioxide stikken, intra-cardiale leegbloeden en cervicale dislocatie. Een schema van de belangrijkste stappen van de procedure zijn weergegeven in figuur 2. Volbloedmonsters door intra-cardiale leegbloeden verzameld werden verwerkt volgens de hierboven beschreven protocol. Daarna werd centrifugeren toegepast om de buffy coat laag die werd onder…

Discussion

In this study, how to isolate and propagate CTCs from the whole blood of a syngeneic mouse with HCC were described. The objective of this work is to enhance the ongoing studies of the mechanisms of cancer metastasis.

A factor that contributes to the poor prognosis of many cancers is the lack of timely detection and consequent widespread dissemination of the malignancy3. CTCs originate from primary cancers and spread via the blood stream to distant organs. As such, CTCs are importan…

Divulgazioni

The authors have nothing to disclose.

Acknowledgements

Work in Dr. Ogunwobi’s laboratory is supported by a Research Centers in Minority Institutions Program grant from the National Institute on Minority Health and Health Disparities (MD007599) of the National Institutes of Health. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the NIMHD or the NIH.

Materials

Heparin Sodium Salt 1G VWR 89508-852
BTX Tube Micro 1.5mL Clear NS VWR 89511-254 1.5mL  pyrogen-free eppendorf Tubes
Needle Sterile Disp BD 25GX1IN VWR BD305125 25G Needle
Slp Tip SRNG 1ml 200 each per pack VWR BD309659 1mL syringe tip
Syringe 1ml leur lok Pk 100 VWR BD309628 1 mL syringe
VWR Forceps Tissue 6 VWR 82027-446 Forceps
Cyromold intrm 15X15X5MM PK 100 VWR 25608-924 Cyromold
Cryo-oct compund 4oz VWR 25608-930 Oct compound
VWR Slide sprfrst 25X75MM PK72 VWR 48311-703 Slides
VWR Cover Glass #2 22X5oMM OZ VWR 48-382-128 Cover Glass
VWR Slide Box True North Fm Pu VWR 89140-278 Slide Box
Super HT PAP Pen VWR 89427-058 PAP pen
Water RNASe and DNAse free 2L VWR 101454-204 Nuclease Free Water
Buffer Tris Ultra Pure Grade 500G VWR 97061-796 Tris Buffer
Ammonium Chloride ACS Grade 2  5KG VWR 97062-048 Ammonium Chloride Buffer
Falcon Tissue Culture Dish 60 x 15mm Style polystyrene VWR 353002 Tissue Culture Dish
Clorox® Germicidal Bleach, Regular VWR 89501-620 Clorox Bleach
PBS, 1X (Phosphate-Buffered Saline) without calcium & magnesium (500mL) Thermo Fischer Scientific 21-040-CV PBS, 1X
DMEM, 1X  with 4.5 g/L glucose & L-glutamine without sodium pyruvate Thermo Fischer Scientific 10-017-CV DMEM 1X media for BNL 1ME A.7R.1 cells
Fetal Bovine Seru8m Thermo Fischer Scientific 35-010-CV FBS
Penicillin Streptomycin Solution, 100X Thermo Fischer Scientific 30-002-Cl Penicillin Streptomycin
Sorvall Biofuge pico Thermo Fischer Scientific 75002411 13000rpm Centrifuge

Riferimenti

  1. Ashworth, T. R. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. Australian Medical Journal. 1869, 146-147 (14).
  2. van de Stolpe, A., den Toonder, J. Circulating Tumor Cells: What Is in It for the Patient? A Vision towards the Future. Cancers. 6, 1195-1207 (2014).
  3. Sheng, W., et al. Capture, release and culture of circulating tumor cells from pancreatic cancer patients using an enhanced mixing chip. Lab on a chip. 14, 89-98 (2014).
  4. George, T. J., Ogunwobi, O. O., Sheng, W., Fan, Z. H., Liu, C. "Tissue is the issue": circulating tumor cells in pancreatic cancer. Journal of gastrointestinal cancer. , (2014).
  5. Ogunwobi, O. O., Puszyk, W., Dong, H. J., Liu, C. Epigenetic upregulation of HGF and c-Met drives metastasis in hepatocellular carcinoma. PloS one. 8, e63765 (2013).
  6. Cheng, B., et al. Transparent, biocompatible nanostructured surfaces for cancer cell capture and culture. International journal of nanomedicine. 9, 2569-2580 (2014).
  7. Yu, M., Stott, S., Toner, M., Maheswaran, S., Haber, D. A. Circulating tumor cells: approaches to isolation and characterization. The Journal of cell biology. 192, 373-382 (2011).
  8. Steube, K. G., Koelz, A. L., Drexler, H. G. Identification and verification of rodent cell lines by polymerase chain reaction. Cytotechnology. 56, 49-56 (2008).
  9. Pantel, K., Alix-Panabieres, C., Riethdorf, S. Cancer micrometastases. Nature reviews. Clinical oncology. 6, 339-351 (2009).
  10. Pantel, K., Brakenhoff, R. H., Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nature reviews. Cancer. 8, 329-340 (2008).
  11. Cristofanilli, M., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. The New England journal of medicine. 351, 781-791 (2004).
  12. De Giorgi, U., et al. Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 21, 33-39 (2010).
  13. Eloubeidi, M. A., et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of patients with suspected pancreatic cancer: diagnostic accuracy and acute and 30-day complications. The American journal of gastroenterology. 98, 2663-2668 (2003).
  14. O’Toole, D., et al. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointestinal endoscopy. 53, 470-474 (2001).
check_url/it/52861?article_type=t

Play Video

Citazione di questo articolo
Das, D. K., Naidoo, M. K., Ilboudo, A., DuBois, P., Durojaiye, V., Liu, C., Ogunwobi, O. O. Isolation and Propagation of Circulating Tumor Cells from a Mouse Cancer Model. J. Vis. Exp. (104), e52861, doi:10.3791/52861 (2015).

View Video